Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney
- 26 December 2017
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 20 (2), e12829
- https://doi.org/10.1111/tid.12829
Abstract
Background HCV-infected (HCV+) ESRD patients derive significant survival benefit from kidney transplantation (KT) over remaining on dialysis. Given high mortality rates on dialysis and the unique ability to accept HCV+ and HCV- donor kidneys, understanding their access to KT is essential. Methods Three thousand nine hundred and sixty-three adult kidney-only candidates reported as willing to accept an HCV+ kidney from 2008 to 2014 were identified and assumed to be HCV+. Time-at-risk began at date of listing. Cumulative incidence of transplant and waitlist mortality were assessed using competing risks, and separate mixed effects Cox proportional hazards models were used to examine waitlist mortality and transplantation rates. All models were adjusted for candidate demographic and clinical characteristics with a random effect for listing organ procurement organization with nested listing center. Results HCV+ candidates were commonly older (>50 years: 82.6%), African American (52.8%), and male (73.6%). Five years after listing, 35.5% of candidates were transplanted with an HCV+ donor kidney, 9.7% transplanted with an HCV- donor kidney, and 23.6% died on the waitlist. Overall transplant rates exceeded waitlist mortality rates (22.69 vs 11.45 per 100 person-years [PY]), largely driven by transplantation with HCV+ donor kidneys. Utilization of HCV+ donor kidneys was associated with increased transplantation rate (17.72 per 100 PY), while rate of transplant with HCV- donor kidneys was much lower (4.97 per 100 PY) than waitlist mortality (11.45 per 100 PY). Conclusion In light of effective HCV therapies, it may be prudent to institute strategies to decrease waiting time and waitlist mortality for HCV+ candidates by increasing utilization of HCV+ donor kidneys.Keywords
This publication has 40 references indexed in Scilit:
- Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive RecipientsAmerican Journal of Transplantation, 2010
- Half of Kidney Transplant Candidates Who Are Older than 60 Years Now Placed on the Waiting List Will Die before Receiving a Deceased-Donor TransplantClinical Journal of the American Society of Nephrology, 2009
- Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysisJournal of Viral Hepatitis, 2007
- Response to 'Viral Hepatitis Guidelines for Transplant Recipients'American Journal of Transplantation, 2005
- The Impact of Transplantation with Deceased Donor Hepatitis C-Positive Kidneys on Survival in Wait-Listed Long-term Dialysis PatientsAmerican Journal of Transplantation, 2004
- Outcome of Hepatitis C Virus-Infected Kidney Transplant Candidates Who Remain on the Waiting ListAmerican Journal of Transplantation, 2004
- Renal transplantation offers a better survival in HCV‐infected ESRD patientsClinical Transplantation, 2004
- Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPSKidney International, 2004
- Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donorsClinical Transplantation, 2000
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999